Defining aggressive prostate cancer using a 12-gene model.
about
LNCaP Atlas: gene expression associated with in vivo progression to castration-recurrent prostate cancerEvaluation of protein biomarkers of prostate cancer aggressivenessNeoplasia: Where We Have Been and Where We Are GoingAn accurate prostate cancer prognosticator using a seven-gene signature plus Gleason score and taking cell type heterogeneity into accountDiscovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomyDevelopment of multigene expression signature maps at the protein level from digitized immunohistochemistry slidesA hierarchical Naïve Bayes Model for handling sample heterogeneity in classification problems: an application to tissue microarrays.Neoplasia: the second decade.Constructing Bayesian networks by integrating gene expression and copy number data identifies NLGN4Y as a novel regulator of prostate cancer progression.Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process.Gene panel model predictive of outcome in men at high-risk of systemic progression and death from prostate cancer after radical retropubic prostatectomy.Identification and validation of potential new biomarkers for prostate cancer diagnosis and prognosis using 2D-DIGE and MS.Prognostic value of discs large homolog 7 transcript levels in prostate cancer.Role of STRAP in regulating GSK3β function and Notch3 stabilization.Protein-network modeling of prostate cancer gene signatures reveals essential pathways in disease recurrence.Dysregulation of the vascular endothelial growth factor and semaphorin ligand-receptor families in prostate cancer metastasis.Expression profiling of uterine leiomyomata cytogenetic subgroups reveals distinct signatures in matched myometrium: transcriptional profilingof the t(12;14) and evidence in support of predisposing genetic heterogeneity.RNA biomarkers to facilitate the identification of aggressive prostate cancerDetection of TMPRSS2-ERG translocations in human prostate cancer by expression profiling using GeneChip Human Exon 1.0 ST arraysMolecular and cytogenetic characterization of plexiform leiomyomata provide further evidence for genetic heterogeneity underlying uterine fibroids.Targeted therapy of cancer: new roles for pathologists--prostate cancer.Aberrant cytoplasmic expression of p63 and prostate cancer mortality.DNA methylome changes by estradiol benzoate and bisphenol A links early-life environmental exposures to prostate cancer riskTumor protein D52 represents a negative regulator of ATM protein levels.Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.Discovery of prostate cancer biomarkers by microarray gene expression profiling.Diagnostic and prognostic molecular biomarkers for prostate cancer.The diverse heterogeneity of molecular alterations in prostate cancer identified through next-generation sequencingThe genomic landscape of prostate cancerClinically relevant genetic characterization of prostate tumors: how close are we to the goal?Nuclear MTA1 overexpression is associated with aggressive prostate cancer, recurrence and metastasis in African Americans.The significance of dynamin 2 expression for prostate cancer progression, prognostication, and therapeutic targeting.Gene panel model predictive of outcome in patients with prostate cancer.Expression of androgen receptor is negatively regulated by p53.Expression profiling of prostate cancer tissue delineates genes associated with recurrence after prostatectomy.The identification of trans-associations between prostate cancer GWAS SNPs and RNA expression differences in tumor-adjacent stroma.Testing a multigene signature of prostate cancer death in the Swedish Watchful Waiting Cohort.Modeling intra-tumor protein expression heterogeneity in tissue microarray experimentsNeoplasia: An Anniversary of Progress.Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer.
P2860
Q21202034-F1CA01EC-3028-4CD6-ADCB-A886EA39FDB0Q21261257-2806AF3A-CD34-45D1-B7A4-BC169AF5B101Q28395095-9581D846-83A2-4C42-96AA-ECD2B1C7B976Q28484126-0157B404-EF12-459E-9340-809B53BF97FEQ28534277-353298F3-4483-4B1A-AB20-37765045E708Q28731283-EB36AD4D-1F4F-4592-A88A-2AB3AF760333Q30478471-0AE3F70B-828D-4928-A6AF-4F69BAE62030Q30484000-EE2DCEA6-0013-4B86-9247-7A051D1B0D47Q31130674-185A64D3-885F-461A-948C-9EE7C09B2A0CQ33281964-58F97A0C-76AF-4D08-8308-CA4942FA6F92Q33361134-97F7B752-ECDB-4A31-9A72-B6DA86833E8EQ35033878-DA25B8A3-8CF5-495B-AA6C-99737ACBC646Q35070576-9384B76C-AA76-405A-A114-E927351A7DA3Q35079336-8817C606-D3A1-44AD-854A-05FECD81C4D2Q35082989-7EEDAA14-AB22-464A-B3C4-F24B5DE5C8C0Q35764986-403C6469-6B52-4216-8557-39F3A73BB83CQ35909440-100BBD5A-A705-4F55-9801-E4B0F80CD28AQ36260364-FF559DC7-421D-4A52-ADDA-F22B021728ADQ36329317-B37B2D66-0E1D-4E4A-94E9-2E306B55CD27Q36579870-B4F4395C-25BE-46B1-8581-F91E9AD40DE1Q37147772-7D7A5009-34AC-4E25-BA09-965579CCD67CQ37216001-075589D0-1CF9-43B4-ABC2-7D240899217FQ37308114-DEEA1825-E82E-4D8B-A9FB-988FAC5A8EA0Q37420061-B7F91FF5-9144-461A-B40C-179E8AC006E2Q37610799-B23A2B9C-FC0C-4CFD-89B3-18536D0DF1A3Q37656262-4EC2EF29-17FB-45EE-9BA0-3E80B916B5CDQ37972703-733B6D59-36CB-444A-B52E-79A60ABD735BQ38090427-690499D0-A9E1-4A1E-8C41-5C1C1A47CB48Q38109474-873BE39E-011F-46FA-A473-EB3272831ED3Q38356863-325EB380-D787-4916-856A-216FD38D6A82Q38395479-05CB79B8-C63E-49B0-B92C-8C5E42F3751CQ39036293-B1177F5E-D2BE-4A41-91AD-6209E5CB4C07Q39403730-2D557034-691B-4440-A8BC-5A84C9FFAFB3Q40034771-8B9A964E-4D83-4B2E-9F5A-8C1B65CEFB21Q40369700-576ED992-3F5B-4C21-8904-CC36259E7702Q42102286-3D4B46CE-2181-4971-A998-4565161BC207Q42532114-4916A0A1-92D7-48A2-B53E-753F7A2A1163Q42570970-E573EC38-28C3-40EA-9D1C-1F5EEB3B4C80Q46932476-B0CDDC9D-1D04-4F8B-A016-2AA5955A392DQ55398136-E4185C4C-F14A-409A-98A0-5C42069C1903
P2860
Defining aggressive prostate cancer using a 12-gene model.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Defining aggressive prostate cancer using a 12-gene model.
@ast
Defining aggressive prostate cancer using a 12-gene model.
@en
type
label
Defining aggressive prostate cancer using a 12-gene model.
@ast
Defining aggressive prostate cancer using a 12-gene model.
@en
prefLabel
Defining aggressive prostate cancer using a 12-gene model.
@ast
Defining aggressive prostate cancer using a 12-gene model.
@en
P2093
P2860
P50
P356
P1433
P1476
Defining aggressive prostate cancer using a 12-gene model.
@en
P2093
Arul M Chinnaiyan
Jeff Kutok
Jeffery Tang
Jonathan C Aster
Matthias D Hofer
Phillip G Febbo
Rainer Kuefer
Robert Kim
Tarek A Bismar
P2860
P356
10.1593/NEO.05664
P577
2006-01-01T00:00:00Z